An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

Stopped early · Phase 3

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to evaluate the long-term safety and tolerability of Dimebon in patients with Alzheimer's disease.

Key facts

Study ID

NCT00939783

Run by

Pfizer

People needed

649

Starts

2009-09-01

Expected to finish

2010-08-01

Last updated by the study team

2012-11-14

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completion of previous Phase 3 Dimebon study (B1451027).

You may not qualify if…

• Have any severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the patient inappropriate for entry into this study.

Where it is running

• Pfizer Investigational Site — Elkhart, Indiana, United States
• Pfizer Investigational Site — Evansville, Indiana, United States
• Pfizer Investigational Site — Fort Wayne, Indiana, United States
• Pfizer Investigational Site — Greenfield, Indiana, United States
• Pfizer Investigational Site — Prairie Village, Kansas, United States
• Pfizer Investigational Site — Wichita, Kansas, United States
• Pfizer Investigational Site — Lake Charles, Louisiana, United States
• Pfizer Investigational Site — New Orleans, Louisiana, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Hyannis, Massachusetts, United States
• Pfizer Investigational Site — Flowood, Mississippi, United States
• Pfizer Investigational Site — Olive Branch, Mississippi, United States
• Pfizer Investigational Site — Springfield, Missouri, United States
• Pfizer Investigational Site — Great Falls, Montana, United States
• Pfizer Investigational Site — Eatontown, New Jersey, United States
• Pfizer Investigational Site — Oakhurst, New Jersey, United States
• Pfizer Investigational Site — Toms River, New Jersey, United States
• Pfizer Investigational Site — Albuquerque, New Mexico, United States
• Pfizer Investigational Site — Amherst, New York, United States
• Pfizer Investigational Site — Buffalo, New York, United States
• Pfizer Investigational Site — Buffalo, New York, United States
• Pfizer Investigational Site — Orchard Park, New York, United States
• Pfizer Investigational Site — Syracuse, New York, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Elk Grove Village, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.